• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间变性与分化型甲状腺癌并存:一项免疫组织化学研究

Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study.

作者信息

Aratake Yatsuki, Nomura Hajime, Kotani Tomio, Marutsuka Kosuke, Kobayashi Kaoru, Kuma Kanji, Miyauchi Akira, Okayama Akihiko, Tamura Kazuo

机构信息

Central Laboratory for Clinical Investigation, Miyazaki University Hospital, Japan.

出版信息

Am J Clin Pathol. 2006 Mar;125(3):399-406.

PMID:16613343
Abstract

The aim of the present study was to clarify the underlying molecules that might contribute to the highly aggressive behavior of anaplastic thyroid carcinoma. We selected 5 cases of anaplastic thyroid carcinoma that had a differentiated area to determine differences in the molecules of undifferentiated and differentiated cancer cells. We immunohistochemically examined the localization of nuclear antigen (Ki-67), proliferating cell nuclear antigen (PCNA), p53, apoptotic protease-activating factor-1 (Apaf-1), CD26, galectin-3, E-cadherin, and CD147. We found increased Ki-67, PCNA, and p53 labeling indices; decreased levels of Apaf-1, CD26, galectin-3, and E-cadherin; and overexpression of CD147 in the undifferentiated area compared with the differentiated area. These findings indicate high proliferative properties, suppression of apoptosis, disruption of cell-cell interaction, and induction of matrix metalloproteinases in the undifferentiated areas. Thus the molecules examined might be useful for evaluating the aggressive nature of this tumor and the prognosis.

摘要

本研究的目的是阐明可能导致间变性甲状腺癌高度侵袭性行为的潜在分子。我们选择了5例具有分化区域的间变性甲状腺癌,以确定未分化和分化癌细胞分子的差异。我们采用免疫组织化学方法检测了核抗原(Ki-67)、增殖细胞核抗原(PCNA)、p53、凋亡蛋白酶激活因子-1(Apaf-1)、CD26、半乳糖凝集素-3、E-钙黏蛋白和CD147的定位。我们发现,与分化区域相比,未分化区域的Ki-67、PCNA和p53标记指数增加;Apaf-1、CD26、半乳糖凝集素-3和E-钙黏蛋白水平降低;CD147过表达。这些发现表明未分化区域具有高增殖特性、细胞凋亡抑制、细胞间相互作用破坏以及基质金属蛋白酶的诱导。因此,所检测的分子可能有助于评估该肿瘤的侵袭性和预后。

相似文献

1
Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study.间变性与分化型甲状腺癌并存:一项免疫组织化学研究
Am J Clin Pathol. 2006 Mar;125(3):399-406.
2
Coexistent Anaplastic and Differentiated Thyroid Carcinoma.并存的间变性和分化型甲状腺癌
Am J Clin Pathol. 2006 Mar;125(3):399-406. doi: 10.1309/LF3Q-1NQK-MT2N-9KNV.
3
Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions.与甲状腺间变性梭形细胞和巨细胞癌相关的乳头状癌和滤泡状癌的组织学变异型:横纹肌样和甲状腺球蛋白包涵体分析
Am J Surg Pathol. 2007 May;31(5):729-36. doi: 10.1097/01.pas.0000213417.00386.74.
4
Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.E-钙黏蛋白/连环蛋白复合体的紊乱与分化型甲状腺癌向间变性甲状腺癌的转变有关。
Am J Surg. 2006 May;191(5):581-7. doi: 10.1016/j.amjsurg.2006.02.005.
5
[Anaplastic carcinoma of the thyroid].
Arch Anat Cytol Pathol. 1998;46(1-2):87-93.
6
Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma.甲状腺乳头状癌弥漫性(或多结节性)滤泡变体:10例侵袭性分化型甲状腺癌的临床病理及免疫组化分析
Virchows Arch. 2002 Apr;440(4):418-24. doi: 10.1007/s00428-001-0543-3. Epub 2001 Dec 12.
7
Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma.
Exp Clin Endocrinol Diabetes. 2002 Jan;110(1):27-31. doi: 10.1055/s-2002-19991.
8
Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.分化型甲状腺癌中甲状腺过氧化物酶和半乳糖凝集素-3免疫染色及其与临床病理的相关性
Hum Pathol. 2008 Nov;39(11):1656-63. doi: 10.1016/j.humpath.2008.04.006. Epub 2008 Jul 26.
9
Genetic mutations in thyroid carcinoma.甲状腺癌中的基因突变
Minerva Endocrinol. 2009 Mar;34(1):11-28.
10
Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma.基质金属蛋白酶-7(MMP-7)和基质金属蛋白酶-11(MMP-11)的表达与甲状腺乳头状癌预后不良的预测指标之间的负相关关系。
Pathology. 2006 Oct;38(5):421-5. doi: 10.1080/00313020600922496.

引用本文的文献

1
Immunohistochemical basigin expression level in thyroid cancer tissues.甲状腺癌组织中免疫组化basigin的表达水平。
World J Surg Oncol. 2020 Sep 5;18(1):240. doi: 10.1186/s12957-020-01975-9.
2
Thyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review).甲状腺肿瘤起始细胞:抗癌治疗的证据日益增多及机遇(综述)
Oncol Rep. 2014 Mar;31(3):1035-42. doi: 10.3892/or.2014.2978. Epub 2014 Jan 14.
3
Stem cells and cancer stem-like cells in endocrine tissues.内分泌组织中的干细胞和癌症干细胞样细胞。
Endocr Pathol. 2013 Mar;24(1):1-10. doi: 10.1007/s12022-013-9235-1.
4
CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy.表达 CD133 的甲状腺癌细胞未分化,对放射抗拒,能在放射性碘治疗中存活。
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):61-71. doi: 10.1007/s00259-012-2242-5. Epub 2012 Oct 19.
5
Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.甲状腺癌中上皮-间充质转化调节因子 SNAI2 和 TWIST1 的表达。
Mod Pathol. 2013 Jan;26(1):54-61. doi: 10.1038/modpathol.2012.137. Epub 2012 Aug 17.
6
Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma.具有多形性肿瘤巨细胞的非典型性甲状腺乳头状癌:与间变性癌的诊断陷阱。
Virchows Arch. 2010 Jun;456(6):661-70. doi: 10.1007/s00428-010-0919-3. Epub 2010 Apr 23.
7
Diagnostic utility of galectin-3 in thyroid cancer.半乳糖凝集素-3 在甲状腺癌中的诊断效用。
Am J Pathol. 2010 May;176(5):2067-81. doi: 10.2353/ajpath.2010.090353. Epub 2010 Apr 2.
8
Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma.半乳糖凝集素-3在甲状腺乳头状癌肿瘤进展和转移中的表达
Endocr Pathol. 2008 Summer;19(2):92-6. doi: 10.1007/s12022-008-9033-3.
9
A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.一种用于区分甲状腺乳头状癌与良性病变的多基因方法:使用带有自抽样法的支持向量机进行基因选择。
Endocr Relat Cancer. 2007 Sep;14(3):809-26. doi: 10.1677/ERC-06-0048.